Vicor Corporation
Vicor releases a DCM™ family of regulated 48V to 12V DC-DC converters
Vicor releases a DCM™ family of regulated 48V to 12V DC-DC converters
High density modules range in power levels from 750W up to 2kW
ANDOVER, Mass., March 26, 2025 (GLOBE NEWSWIRE) -- Vicor has released a new DCM family that supports 48V-centric power delivery networks with greater system efficiency and performance. The DCMs (DCM3717 and DCM3735) range in power levels from 750W up to 2kW and provide an industry-leading power density of 5kW/in3. Power system designers requiring scalable solutions can parallel devices for higher power capability.
Vicor DCM3717 and DCM3735, non-isolated regulated 48V-12V converters ease the migration to 48V power delivery. (Download high res image)
Learn more about the Vicor DCM3717 and DCM3735.
Follow Vicor on Social Media
Twitter: @VicorPower »
Vicor Corporation on LinkedIn »
About Vicor Corporation
Vicor Corporation designs, develops, manufactures and markets modular power components and complete power systems based upon a portfolio of patented technologies. Headquartered in Andover, Massachusetts, Vicor sells its products to the power systems market, including enterprise and high-performance computing, industrial equipment and automation, telecommunications and network infrastructure, vehicles and transportation, aerospace and defense. www.vicorpower.com
Vicor is a registered trademark and DCM™ is a trademark of Vicor Corporation.
Contact
Stephen Germino
Director of Media Relations
978 749-8243
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/7f49cfb9-b938-4667-af76-da4fcac5eb22

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Gatorade31.5.2025 17:39:49 CEST | Press release
Gatorade 5v5 Finals Bring Global Youth to Champions League Stage in Munich
F. Hoffmann-La Roche Ltd31.5.2025 14:05:00 CEST | Press release
New data show Roche’s Itovebi significantly extended survival in a certain type of HR-positive advanced breast cancer
Ipsen Pharma31.5.2025 14:00:00 CEST | Press release
Late-breaking analysis demonstrates characteristics associated with long-term overall survival with Onivyde® regimen in metastatic pancreatic adenocarcinoma
WithSecure Oyj31.5.2025 08:45:00 CEST | Press release
WithSecure has completed the transaction of Cyber security consulting divestment to Neqst
Teva Pharmaceutical Industries Ltd31.5.2025 03:05:00 CEST | Press release
New Data from Teva Shows Substantial Rates of Undertreated Tardive Dyskinesia in Long-Term Care Settings at Psych Congress Elevate 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom